Powered by: Motilal Oswal
2024-11-13 11:41:35 am | Source: Accord Fintech
Krishna Institute of Medical Sciences trades higher on the BSE

Krishna Institute of Medical Sciences is currently trading at Rs. 558.40, up by 1.90 points or 0.34% from its previous closing of Rs. 556.50 on the BSE.

The scrip opened at Rs. 550.70 and has touched a high and low of Rs. 561.55 and Rs. 546.10 respectively. So far 16100 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 603.95 on 11-Nov-2024 and a 52 week low of Rs. 350.02 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 603.95 and Rs. 546.10 respectively. The current market cap of the company is Rs. 22087.67 crore.

The promoters holding in the company stood at 38.82%, while Institutions and Non-Institutions held 48.15% and 13.03% respectively.

Krishna Institute of Medical Sciences (KIMS) has entered into an Operations and Management Agreement with Insignia Healthcare for initial term of 15 years with an extension for a further period of 10 years to operate, manage and to provide healthcare medical services to a newly constructed super specialty hospital having around 150 bed capacity at Guntur-Andhra Pradesh.

The Super Specialty Hospital will be under the exclusive supervision and control of KIMS, and shall be branded as ‘KIMS-SIKHARA’. KIMS shall be solely responsible for its operation and efficient management. 

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here